What's new | Periotherapia Co., Ltd.

JP
EN

TOP Company Introduction

Company Introduction

Company Introduction Executive Introduction Company Overview

Executive Introduction Company Overview Research and Development Pipeline What's new Inquiry

JP
EN

News

TOP What’s new

All

Funding-related Clinical Trial Progress Joint Research and Licensing Media Relations Awards and Selections Notices

2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …

投稿のページ送り

1 2

2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …

投稿のページ送り

1 2

2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …

投稿のページ送り

1 2

2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …

投稿のページ送り

1 2

2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …

投稿のページ送り

1 2

2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …

投稿のページ送り

1 2

2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …

投稿のページ送り

1 2

Contact

For any questions or enquiries,
please contact us here

Contact

Periotherapia Co., Ltd.
2-2 Yamadaoka, Suita City, Osaka Prefecture
565-0871
TEL: +81 6-6210-8409
FAX: +81 6-6210-8346

Company Introduction Executive Introduction Company Overview Research and Development Pipeline What's new Inquiry

Copyright © 2024 Periotherapia Co.,Ltd. All Rights Reserved.